Mark L. Berch

Array ( [id] => 334402 [patent_doc_number] => 07507814 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-03-24 [patent_title] => 'Process for preparation of imipenem' [patent_app_type] => utility [patent_app_number] => 10/563250 [patent_app_country] => US [patent_app_date] => 2004-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 3962 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/507/07507814.pdf [firstpage_image] =>[orig_patent_app_number] => 10563250 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7051341 [patent_doc_number] => 20050187228 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-25 [patent_title] => 'Derivatives of purine, their preparation process and pharmaceutical compositions containing them' [patent_app_type] => utility [patent_app_number] => 11/006013 [patent_app_country] => US [patent_app_date] => 2004-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 50205 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0187/20050187228.pdf [firstpage_image] =>[orig_patent_app_number] => 11006013 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 443084 [patent_doc_number] => 07256196 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-08-14 [patent_title] => 'Purine cytokine inhibitors' [patent_app_type] => utility [patent_app_number] => 11/006095 [patent_app_country] => US [patent_app_date] => 2004-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18244 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 298 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/256/07256196.pdf [firstpage_image] =>[orig_patent_app_number] => 11006095 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6918737 [patent_doc_number] => 20050096298 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-05 [patent_title] => 'Novel perines' [patent_app_type] => utility [patent_app_number] => 10/994962 [patent_app_country] => US [patent_app_date] => 2004-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30270 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0096/20050096298.pdf [firstpage_image] =>[orig_patent_app_number] => 10994962 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 880543 [patent_doc_number] => 07355040 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-04-08 [patent_title] => 'Process for the preparation of cephalosporin compounds and synthetic intermediates' [patent_app_type] => utility [patent_app_number] => 10/994983 [patent_app_country] => US [patent_app_date] => 2004-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7736 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/355/07355040.pdf [firstpage_image] =>[orig_patent_app_number] => 10994983 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 74724 [patent_doc_number] => 07750148 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-07-06 [patent_title] => 'Intermediate compound for the production of β-lactamase-resistant cephalosporin ester compounds and salts thereof' [patent_app_type] => utility [patent_app_number] => 10/580561 [patent_app_country] => US [patent_app_date] => 2004-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7094 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/750/07750148.pdf [firstpage_image] =>[orig_patent_app_number] => 10580561 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 919883 [patent_doc_number] => 07321035 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-01-22 [patent_title] => 'Process for producing 2,6-dihalogenopurine' [patent_app_type] => utility [patent_app_number] => 10/991505 [patent_app_country] => US [patent_app_date] => 2004-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4531 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/321/07321035.pdf [firstpage_image] =>[orig_patent_app_number] => 10991505 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7255427 [patent_doc_number] => 20050075349 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-07 [patent_title] => 'Xanthine phosphodiesterase V inhibitors' [patent_app_type] => utility [patent_app_number] => 10/990083 [patent_app_country] => US [patent_app_date] => 2004-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15448 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0075/20050075349.pdf [firstpage_image] =>[orig_patent_app_number] => 10990083 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5253998 [patent_doc_number] => 20070135454 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-14 [patent_title] => 'Bicyclic pyrimidin-4(3h)-ones and analogues and derivatives thereof which modulate the function of the vanilloid-1-receptor(vr1)' [patent_app_type] => utility [patent_app_number] => 10/578855 [patent_app_country] => US [patent_app_date] => 2004-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29269 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0135/20070135454.pdf [firstpage_image] =>[orig_patent_app_number] => 10578855 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6912949 [patent_doc_number] => 20050176707 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-11 [patent_title] => 'Compositions and methods for inducing cell dedifferentiation' [patent_app_type] => utility [patent_app_number] => 10/985645 [patent_app_country] => US [patent_app_date] => 2004-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 13293 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20050176707.pdf [firstpage_image] =>[orig_patent_app_number] => 10985645 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 919762 [patent_doc_number] => 07320972 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-01-22 [patent_title] => '4-Biarylyl-1-phenylazetidin-2-ones' [patent_app_type] => utility [patent_app_number] => 10/986570 [patent_app_country] => US [patent_app_date] => 2004-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 60427 [patent_no_of_claims] => 71 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/320/07320972.pdf [firstpage_image] =>[orig_patent_app_number] => 10986570 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7005811 [patent_doc_number] => 20050171124 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-04 [patent_title] => 'Famciclovir monohydrate' [patent_app_type] => utility [patent_app_number] => 10/980469 [patent_app_country] => US [patent_app_date] => 2004-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1130 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20050171124.pdf [firstpage_image] =>[orig_patent_app_number] => 10980469 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7098526 [patent_doc_number] => 20050130985 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-16 [patent_title] => '8-(piperazin-1yl)- and 8-([1,4]diazepan-1yl)-xanthines, the preparation thereof and their use as pharmaceutical composition' [patent_app_type] => utility [patent_app_number] => 10/979468 [patent_app_country] => US [patent_app_date] => 2004-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6775 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20050130985.pdf [firstpage_image] =>[orig_patent_app_number] => 10979468 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4840607 [patent_doc_number] => 20080281093 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-13 [patent_title] => 'Novel Process For Preparation of Cefprozil Intermediate' [patent_app_type] => utility [patent_app_number] => 10/595544 [patent_app_country] => US [patent_app_date] => 2004-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1867 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20080281093.pdf [firstpage_image] =>[orig_patent_app_number] => 10595544 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 292504 [patent_doc_number] => 07544797 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-06-09 [patent_title] => 'Processes for the preparation of cephem derivatives' [patent_app_type] => utility [patent_app_number] => 10/577552 [patent_app_country] => US [patent_app_date] => 2004-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5404 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/544/07544797.pdf [firstpage_image] =>[orig_patent_app_number] => 10577552 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 211671 [patent_doc_number] => 07622577 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-11-24 [patent_title] => 'Processes for the preparation of cephalosporin derivatives' [patent_app_type] => utility [patent_app_number] => 10/577551 [patent_app_country] => US [patent_app_date] => 2004-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2806 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/622/07622577.pdf [firstpage_image] =>[orig_patent_app_number] => 10577551 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6997404 [patent_doc_number] => 20050137182 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-23 [patent_title] => 'Novel crystalline form of cefdinir' [patent_app_type] => utility [patent_app_number] => 10/976230 [patent_app_country] => US [patent_app_date] => 2004-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3571 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20050137182.pdf [firstpage_image] =>[orig_patent_app_number] => 10976230 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5253901 [patent_doc_number] => 20070135357 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-14 [patent_title] => 'Anti-hypercholesterolemic compounds' [patent_app_type] => utility [patent_app_number] => 10/577204 [patent_app_country] => US [patent_app_date] => 2004-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14251 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0135/20070135357.pdf [firstpage_image] =>[orig_patent_app_number] => 10577204 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 686911 [patent_doc_number] => 07078408 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-07-18 [patent_title] => '[1,2,4]-Triazole bicyclic adenosine A2a receptor antagonists' [patent_app_type] => utility [patent_app_number] => 10/973642 [patent_app_country] => US [patent_app_date] => 2004-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11506 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/078/07078408.pdf [firstpage_image] =>[orig_patent_app_number] => 10973642 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5051923 [patent_doc_number] => 20070032468 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-08 [patent_title] => 'Novel thioxanthine derivatives for use as inhibitors of mpo' [patent_app_type] => utility [patent_app_number] => 10/575592 [patent_app_country] => US [patent_app_date] => 2004-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4162 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20070032468.pdf [firstpage_image] =>[orig_patent_app_number] => 10575592 [rel_patent_id] =>[rel_patent_doc_number] =>)